Table of Content

1 Study Coverage
1.1 Endothelin Antagonist Therapy Product Introduction
1.2 Global Endothelin Antagonist Therapy Outlook 2018 VS 2024 VS 2034
1.2.1 Global Endothelin Antagonist Therapy Market Size for the Year 2018-2034
1.2.2 India Endothelin Antagonist Therapy Market Size for the Year 2018-2034
1.3 Endothelin Antagonist Therapy Market Size, India VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of India Endothelin Antagonist Therapy in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Endothelin Antagonist Therapy Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4 Endothelin Antagonist Therapy Market Dynamics
1.4.1 Endothelin Antagonist Therapy Industry Trends
1.4.2 Endothelin Antagonist Therapy Market Drivers
1.4.3 Endothelin Antagonist Therapy Market Challenges
1.4.4 Endothelin Antagonist Therapy Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Endothelin Antagonist Therapy by Type
2.1 Endothelin Antagonist Therapy Market Segment by Type
2.1.1 Oral
2.1.2 Parenteral
2.2 Global Endothelin Antagonist Therapy Market Size by Type (2018, 2024 & 2034)
2.3 Global Endothelin Antagonist Therapy Market Size by Type (2018-2034)
2.4 India Endothelin Antagonist Therapy Market Size by Type (2018, 2024 & 2034)
2.5 India Endothelin Antagonist Therapy Market Size by Type (2018-2034)
3 Endothelin Antagonist Therapy by Application
3.1 Endothelin Antagonist Therapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.1.3 Diagnostic Centers
3.1.4 Others
3.2 Global Endothelin Antagonist Therapy Market Size by Application (2018, 2024 & 2034)
3.3 Global Endothelin Antagonist Therapy Market Size by Application (2018-2034)
3.4 India Endothelin Antagonist Therapy Market Size by Application (2018, 2024 & 2034)
3.5 India Endothelin Antagonist Therapy Market Size by Application (2018-2034)
4 Global Endothelin Antagonist Therapy Competitor Landscape by Company
4.1 Global Endothelin Antagonist Therapy Market Size by Company
4.1.1 Global Key Companies of Endothelin Antagonist Therapy, Ranked by Revenue (2024)
4.1.2 Global Endothelin Antagonist Therapy Revenue by Player (2018-2023)
4.2 Global Endothelin Antagonist Therapy Concentration Ratio (CR)
4.2.1 Endothelin Antagonist Therapy Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Endothelin Antagonist Therapy in 2024
4.2.3 Global Endothelin Antagonist Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Endothelin Antagonist Therapy Head office and Area Served
4.4 Global Key Players of Endothelin Antagonist Therapy, Product and Application
4.5 Global Key Players of Endothelin Antagonist Therapy, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Endothelin Antagonist Therapy Market Size by Company
4.7.1 Key Players of Endothelin Antagonist Therapy in India, Ranked by Revenue (2024)
4.7.2 India Endothelin Antagonist Therapy Revenue by Players (2021, 2024 & 2023)
5 Global Endothelin Antagonist Therapy Market Size by Region
5.1 Global Endothelin Antagonist Therapy Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Endothelin Antagonist Therapy Market Size by Region (2018-2034)
5.2.1 Global Endothelin Antagonist Therapy Market Size by Region: 2018-2023
5.2.2 Global Endothelin Antagonist Therapy Market Size by Region (2024-2034)
6 Americas
6.1 Americas Endothelin Antagonist Therapy Market Size YoY Growth 2018-2034
6.2 Americas Endothelin Antagonist Therapy Market Size by Type
6.2.1 Americas Endothelin Antagonist Therapy Market Size by Type (2018-2023)
6.2.2 Americas Endothelin Antagonist Therapy Market Size by Type (2024-2034)
6.2.3 Americas Endothelin Antagonist Therapy Market Share by Type (2018-2034)
6.3 Americas Endothelin Antagonist Therapy Market Size by Application
6.3.1 Americas Endothelin Antagonist Therapy Market Size by Application (2018-2023)
6.3.2 Americas Endothelin Antagonist Therapy Market Size by Application (2024-2034)
6.3.3 Americas Endothelin Antagonist Therapy Market Share by Application (2018-2034)
6.4 Americas Endothelin Antagonist Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Endothelin Antagonist Therapy Market Size YoY Growth 2018-2034
7.2 EMEA Endothelin Antagonist Therapy Market Size by Type
7.2.1 EMEA Endothelin Antagonist Therapy Market Size by Type (2018-2023)
7.2.2 EMEA Endothelin Antagonist Therapy Market Size by Type (2024-2034)
7.2.3 EMEA Endothelin Antagonist Therapy Market Share by Type (2018-2034)
7.3 EMEA Endothelin Antagonist Therapy Market Size by Application
7.3.1 EMEA Endothelin Antagonist Therapy Market Size by Application (2018-2023)
7.3.2 EMEA Endothelin Antagonist Therapy Market Size by Application (2024-2034)
7.3.3 EMEA Endothelin Antagonist Therapy Market Share by Application (2018-2034)
7.4 EMEA Endothelin Antagonist Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Endothelin Antagonist Therapy Market Size YoY Growth 2018-2034
8.2 China Endothelin Antagonist Therapy Market Size by Type
8.2.1 China Endothelin Antagonist Therapy Market Size by Type (2018-2023)
8.2.2 China Endothelin Antagonist Therapy Market Size by Type (2024-2034)
8.2.3 China Endothelin Antagonist Therapy Market Share by Type (2018-2034)
8.3 China Endothelin Antagonist Therapy Market Size by Application
8.3.1 China Endothelin Antagonist Therapy Market Size by Application (2018-2023)
8.3.2 China Endothelin Antagonist Therapy Market Size by Application (2024-2034)
8.3.3 China Endothelin Antagonist Therapy Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Endothelin Antagonist Therapy Market Size YoY Growth 2018-2034
9.2 APAC Endothelin Antagonist Therapy Market Size by Type
9.2.1 APAC Endothelin Antagonist Therapy Market Size by Type (2018-2023)
9.2.2 APAC Endothelin Antagonist Therapy Market Size by Type (2024-2034)
9.2.3 APAC Endothelin Antagonist Therapy Market Share by Type (2018-2034)
9.3 APAC Endothelin Antagonist Therapy Market Size by Application
9.3.1 APAC Endothelin Antagonist Therapy Market Size by Application (2018-2023)
9.3.2 APAC Endothelin Antagonist Therapy Market Size by Application (2024-2034)
9.3.3 APAC Endothelin Antagonist Therapy Market Share by Application (2018-2034)
9.4 APAC Endothelin Antagonist Therapy Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Gilead Sciences
10.1.1 Gilead Sciences Company Details
10.1.2 Gilead Sciences Business Overview
10.1.3 Gilead Sciences Endothelin Antagonist Therapy Introduction
10.1.4 Gilead Sciences Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.1.5 Gilead Sciences Recent Development
10.2 Sun Pharmaceutical Industries
10.2.1 Sun Pharmaceutical Industries Company Details
10.2.2 Sun Pharmaceutical Industries Business Overview
10.2.3 Sun Pharmaceutical Industries Endothelin Antagonist Therapy Introduction
10.2.4 Sun Pharmaceutical Industries Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.2.5 Sun Pharmaceutical Industries Recent Development
10.3 Lupin
10.3.1 Lupin Company Details
10.3.2 Lupin Business Overview
10.3.3 Lupin Endothelin Antagonist Therapy Introduction
10.3.4 Lupin Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.3.5 Lupin Recent Development
10.4 Zydus Group
10.4.1 Zydus Group Company Details
10.4.2 Zydus Group Business Overview
10.4.3 Zydus Group Endothelin Antagonist Therapy Introduction
10.4.4 Zydus Group Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.4.5 Zydus Group Recent Development
10.5 Endo International
10.5.1 Endo International Company Details
10.5.2 Endo International Business Overview
10.5.3 Endo International Endothelin Antagonist Therapy Introduction
10.5.4 Endo International Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.5.5 Endo International Recent Development
10.6 Mylan N.V
10.6.1 Mylan N.V Company Details
10.6.2 Mylan N.V Business Overview
10.6.3 Mylan N.V Endothelin Antagonist Therapy Introduction
10.6.4 Mylan N.V Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.6.5 Mylan N.V Recent Development
10.7 Teva Pharmaceutical Industries
10.7.1 Teva Pharmaceutical Industries Company Details
10.7.2 Teva Pharmaceutical Industries Business Overview
10.7.3 Teva Pharmaceutical Industries Endothelin Antagonist Therapy Introduction
10.7.4 Teva Pharmaceutical Industries Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.7.5 Teva Pharmaceutical Industries Recent Development
10.8 Sigmapharm Laboratories
10.8.1 Sigmapharm Laboratories Company Details
10.8.2 Sigmapharm Laboratories Business Overview
10.8.3 Sigmapharm Laboratories Endothelin Antagonist Therapy Introduction
10.8.4 Sigmapharm Laboratories Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.8.5 Sigmapharm Laboratories Recent Development
10.9 Alembic Pharmaceuticals
10.9.1 Alembic Pharmaceuticals Company Details
10.9.2 Alembic Pharmaceuticals Business Overview
10.9.3 Alembic Pharmaceuticals Endothelin Antagonist Therapy Introduction
10.9.4 Alembic Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.9.5 Alembic Pharmaceuticals Recent Development
10.10 Hikma Pharmaceuticals
10.10.1 Hikma Pharmaceuticals Company Details
10.10.2 Hikma Pharmaceuticals Business Overview
10.10.3 Hikma Pharmaceuticals Endothelin Antagonist Therapy Introduction
10.10.4 Hikma Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.10.5 Hikma Pharmaceuticals Recent Development
10.11 Amneal Pharmaceuticals
10.11.1 Amneal Pharmaceuticals Company Details
10.11.2 Amneal Pharmaceuticals Business Overview
10.11.3 Amneal Pharmaceuticals Endothelin Antagonist Therapy Introduction
10.11.4 Amneal Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.11.5 Amneal Pharmaceuticals Recent Development
10.12 AstraZeneca
10.12.1 AstraZeneca Company Details
10.12.2 AstraZeneca Business Overview
10.12.3 AstraZeneca Endothelin Antagonist Therapy Introduction
10.12.4 AstraZeneca Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.12.5 AstraZeneca Recent Development
10.13 Johnsons & Johnsons Private limited
10.13.1 Johnsons & Johnsons Private limited Company Details
10.13.2 Johnsons & Johnsons Private limited Business Overview
10.13.3 Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Introduction
10.13.4 Johnsons & Johnsons Private limited Revenue in Endothelin Antagonist Therapy Business (2018-2023)
10.13.5 Johnsons & Johnsons Private limited Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Endothelin Antagonist Therapy Market Size India VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Endothelin Antagonist Therapy Market Trends
Table 3. Endothelin Antagonist Therapy Market Drivers
Table 4. Endothelin Antagonist Therapy Market Challenges
Table 5. Endothelin Antagonist Therapy Market Restraints
Table 6. Global Endothelin Antagonist Therapy Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Endothelin Antagonist Therapy Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Endothelin Antagonist Therapy Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Endothelin Antagonist Therapy Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Endothelin Antagonist Therapy, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Endothelin Antagonist Therapy Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Endothelin Antagonist Therapy Revenue Share by Player, 2018-2023
Table 13. Global Endothelin Antagonist Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Endothelin Antagonist Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endothelin Antagonist Therapy as of 2024)
Table 15. Global Key Players of Endothelin Antagonist Therapy, Headquarters and Area Served
Table 16. Global Key Players of Endothelin Antagonist Therapy, Product and Application
Table 17. Global Key Players of Endothelin Antagonist Therapy, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Endothelin Antagonist Therapy in India, Ranked by Revenue (2024) & (US$ Million)
Table 20. India Endothelin Antagonist Therapy Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. India Endothelin Antagonist Therapy Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Endothelin Antagonist Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Endothelin Antagonist Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Endothelin Antagonist Therapy Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Endothelin Antagonist Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Endothelin Antagonist Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Endothelin Antagonist Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Endothelin Antagonist Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Endothelin Antagonist Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Endothelin Antagonist Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Endothelin Antagonist Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Endothelin Antagonist Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Endothelin Antagonist Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Endothelin Antagonist Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Endothelin Antagonist Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Endothelin Antagonist Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Endothelin Antagonist Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Endothelin Antagonist Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Endothelin Antagonist Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Endothelin Antagonist Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Endothelin Antagonist Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Endothelin Antagonist Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Endothelin Antagonist Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Endothelin Antagonist Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Endothelin Antagonist Therapy Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Endothelin Antagonist Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Endothelin Antagonist Therapy Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Endothelin Antagonist Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Endothelin Antagonist Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Endothelin Antagonist Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 51. Gilead Sciences Company Details
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Endothelin Antagonist Therapy Product
Table 54. Gilead Sciences Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Sun Pharmaceutical Industries Company Details
Table 57. Sun Pharmaceutical Industries Business Overview
Table 58. Sun Pharmaceutical Industries Endothelin Antagonist Therapy Product
Table 59. Sun Pharmaceutical Industries Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 60. Sun Pharmaceutical Industries Recent Development
Table 61. Lupin Company Details
Table 62. Lupin Business Overview
Table 63. Lupin Endothelin Antagonist Therapy Product
Table 64. Lupin Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 65. Lupin Recent Development
Table 66. Zydus Group Company Details
Table 67. Zydus Group Business Overview
Table 68. Zydus Group Endothelin Antagonist Therapy Product
Table 69. Zydus Group Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 70. Zydus Group Recent Development
Table 71. Endo International Company Details
Table 72. Endo International Business Overview
Table 73. Endo International Endothelin Antagonist Therapy Product
Table 74. Endo International Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 75. Endo International Recent Development
Table 76. Mylan N.V Company Details
Table 77. Mylan N.V Business Overview
Table 78. Mylan N.V Endothelin Antagonist Therapy Product
Table 79. Mylan N.V Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 80. Mylan N.V Recent Development
Table 81. Teva Pharmaceutical Industries Company Details
Table 82. Teva Pharmaceutical Industries Business Overview
Table 83. Teva Pharmaceutical Industries Endothelin Antagonist Therapy Product
Table 84. Teva Pharmaceutical Industries Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 85. Teva Pharmaceutical Industries Recent Development
Table 86. Sigmapharm Laboratories Company Details
Table 87. Sigmapharm Laboratories Business Overview
Table 88. Sigmapharm Laboratories Endothelin Antagonist Therapy Product
Table 89. Sigmapharm Laboratories Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 90. Sigmapharm Laboratories Recent Development
Table 91. Alembic Pharmaceuticals Company Details
Table 92. Alembic Pharmaceuticals Business Overview
Table 93. Alembic Pharmaceuticals Endothelin Antagonist Therapy Product
Table 94. Alembic Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 95. Alembic Pharmaceuticals Recent Development
Table 96. Hikma Pharmaceuticals Company Details
Table 97. Hikma Pharmaceuticals Business Overview
Table 98. Hikma Pharmaceuticals Endothelin Antagonist Therapy Product
Table 99. Hikma Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 100. Hikma Pharmaceuticals Recent Development
Table 101. Amneal Pharmaceuticals Company Details
Table 102. Amneal Pharmaceuticals Business Overview
Table 103. Amneal Pharmaceuticals Endothelin Antagonist Therapy Product
Table 104. Amneal Pharmaceuticals Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 105. Amneal Pharmaceuticals Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Endothelin Antagonist Therapy Product
Table 109. AstraZeneca Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 110. AstraZeneca Recent Development
Table 111. Johnsons & Johnsons Private limited Company Details
Table 112. Johnsons & Johnsons Private limited Business Overview
Table 113. Johnsons & Johnsons Private limited Endothelin Antagonist Therapy Product
Table 114. Johnsons & Johnsons Private limited Revenue in Endothelin Antagonist Therapy Business (2018-2023) & (US$ Million)
Table 115. Johnsons & Johnsons Private limited Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Endothelin Antagonist Therapy Product Picture
Figure 2. Global Endothelin Antagonist Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Endothelin Antagonist Therapy Market Size 2018-2034 (US$ Million)
Figure 4. India Endothelin Antagonist Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. India Endothelin Antagonist Therapy Market Size 2018-2034 (US$ Million)
Figure 6. India Endothelin Antagonist Therapy Market Share in Global 2018-2034
Figure 7. Endothelin Antagonist Therapy Report Years Considered
Figure 8. Product Picture of Oral
Figure 9. Product Picture of Parenteral
Figure 10. Global Endothelin Antagonist Therapy Market Share by Type in 2024 & 2034
Figure 11. Global Endothelin Antagonist Therapy Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 13. India Endothelin Antagonist Therapy Market Share by Type in 2024 & 2034
Figure 14. India Endothelin Antagonist Therapy Market Size by Type (2018-2034) & (US$ Million)
Figure 15. India Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Specialty Clinics
Figure 18. Product Picture of Diagnostic Centers
Figure 19. Product Picture of Others
Figure 20. Global Endothelin Antagonist Therapy Market Share by Application in 2024 & 2034
Figure 21. Global Endothelin Antagonist Therapy Market Size by Application (2018-2034) & (US$ Million)
Figure 22. Global Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 23. India Endothelin Antagonist Therapy Market Share by Application in 2024 & 2034
Figure 24. India Endothelin Antagonist Therapy Market Size by Application (2018-2034) & (US$ Million)
Figure 25. India Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 26. The Top 5 and 10 Largest Companies of Endothelin Antagonist Therapy in the World: Market Share by Endothelin Antagonist Therapy Revenue in 2024
Figure 27. Global Endothelin Antagonist Therapy Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 28. Global Endothelin Antagonist Therapy Market Share by Region (2018-2034)
Figure 29. Americas Endothelin Antagonist Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 30. Americas Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 31. Americas Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 32. United States Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Canada Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Mexico Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Brazil Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. EMEA Endothelin Antagonist Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 37. EMEA Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 38. EMEA Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 39. Europe Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Middle East Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Africa Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Endothelin Antagonist Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 43. China Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 44. China Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 45. APAC Endothelin Antagonist Therapy Market Size Growth Rate 2018-2034 (US$ Million)
Figure 46. APAC Endothelin Antagonist Therapy Market Share by Type (2018-2034)
Figure 47. APAC Endothelin Antagonist Therapy Market Share by Application (2018-2034)
Figure 48. Japan Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. South Korea Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. China Taiwan Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. Southeast Asia Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. India Endothelin Antagonist Therapy Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Gilead Sciences Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 55. Lupin Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 56. Zydus Group Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 57. Endo International Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 58. Mylan N.V Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 59. Teva Pharmaceutical Industries Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 60. Sigmapharm Laboratories Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 61. Alembic Pharmaceuticals Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 62. Hikma Pharmaceuticals Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 63. Amneal Pharmaceuticals Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 65. Johnsons & Johnsons Private limited Revenue Growth Rate in Endothelin Antagonist Therapy Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed